IMMUNOPRECISE ANTIBODIES LTD
(NASDAQ: IPA)
ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.
1.280
-
(-%)
Range
- - -
(-%)
Open
-
Previous Close
1.280
Bid Price
2.900
Bid Volume
11
Ask Price
2.960
Ask Volume
9
Volume
187
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis